Table 4.
Characteristics of patients with fatal and non-fatal hospitalizing COVID-19 infections
| Characteristic | Dead group (n = 675) | Surviving group (n = 2,750) | Total (n = 3,425) |
|---|---|---|---|
| Agea (yr) | 63 (55–71) | 57 (47–66) | 58 (48–67) |
| Vaccination statusa | |||
| No. of patients with COVID-19 vaccination | 221 (32.7) | 1,238 (45.0) | 1,459 (42.6) |
| No. of patients without COVID-19 vaccination | 454 (67.3) | 1,512 (55.0) | 1,966 (57.4) |
| Doses of vaccinationa | |||
| No. of patients with a single dose | 178 (80.5) | 773 (62.4) | 951 (65.2) |
| No. of patients with two doses | 42 (19.0) | 452 (36.5) | 494 (33.9) |
| No. of patients with at least three doses | 1 (0.5) | 13 (1.1) | 14 (1.0) |
| Any mRNA vaccine | 5 (2.3) | 54 (4.4) | 59 (4.0) |
| Interval between the last vaccination and admission date (day)a | |||
| Single dose | 24.0 (13.2–43.8) | 29.0 (15.0–53.0) | 27.0 (15.0–52.0) |
| Two doses | 17.0 (7.0–48.0) | 40.0 (19.0–70.2) | 39.5 (17.2–69.0) |
| At least three doses | NA | NA | NA |
| All doses of vaccination | 24.0 (12.0–45.0) | 32.0 (16.0–59.8) | 30.0 (15.0–58.0) |
Data are expressed as median (interquartile range) or number (%).
COVID 19, coronavirus disease 2019; mRNA, messenger RNA; NA, not available.
a
p < 0.05 compared between dead and surviving groups.